The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...

Update, December 12: As a technical matter, commenter Laurie Fenton Ambrose is correct that CMS did not officially propose coverage with evidence development (CED), and this post has been edited to ...

Research Report Closing the CX Gap: Leaders vs. Customers 81% of leaders use AI, 74% of customers still pick up the phone and the gap is costing loyalty Read now eBook Cut Through the AI Noise: Your ...

CMS announced a new funding opportunity for development, improvement and expansion of quality measures for the Quality Payment Program. Over three years, the agency will provide up to $30 million in ...